Kriya Therapeutics, Inc.
Clinical trials sponsored by Kriya Therapeutics, Inc., explained in plain language.
-
Gene therapy injection aims to slow vision loss from dry AMD
Disease control Recruiting nowThis study tests a new gene therapy (VV-14295) given as an injection into the eye for people with geographic atrophy, a form of advanced dry age-related macular degeneration that causes blind spots. The goal is to see if it is safe and can slow the growth of these blind spots. Ab…
Phase: PHASE1, PHASE2 • Sponsor: Kriya Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New combo therapy aims to calm face pain attacks
Symptom relief Recruiting nowThis early-stage study tests whether an injection of RP-008 followed by a daily varenicline pill is safe and can reduce pain for people with trigeminal neuralgia, a condition causing severe facial pain attacks. About 24 adults aged 18-80 with classic or idiopathic trigeminal neur…
Phase: PHASE1, PHASE2 • Sponsor: Kriya Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC